Latest News and Press Releases

STOCKHOLM, Sweden and SAN DIEGO, Dec. 14, 2004 (PRIMEZONE) -- Biovitrum AB and Discovery Partners International, Inc. (Nasdaq:DPII) today announced that they have entered into a drug discovery and...

STOCKHOLM, Sweden and MOSCOW, Nov. 24, 2004 (PRIMEZONE) -- ASINEX Ltd, a worldwide leader in lead generation and lead optimization, and Biovitrum AB, a European Biotech company focusing on metabolic...

STOCKHOLM, Sweden, Nov. 04, 2004 (PRIMEZONE) -- The biotechnology company Biovitrum has decided to divide its research and development operations into two parts. The aim is to increase the focus on...

STOCKHOLM, Sweden and PRINCETON, N.J., Oct. 26, 2004 (PRIMEZONE) -- Biovitrum AB and Pharmacopeia Drug Discovery, Inc. (Nasdaq:PCOP) today announced that they have entered into a multi-year drug...

CHESTERFORD RESEARCH PARK, U.K. and STOCKHOLM, Sweden, Sept. 22, 2004 (PRIMEZONE) -- BioFocus plc (AIM:BIO), a world leader in drug discovery, and Biovitrum today announce that Biovitrum has acquired...

STOCKHOLM, Sweden, Aug. 26, 2004 (PRIMEZONE) -- Biovitrum today announces that the company acquires a promising oncology project from Axelar AB, an innovative company established by leading...

STOCKHOLM, Sweden, July 16, 2004 (PRIMEZONE) -- Medivir and Biovitrum today announce that they initiate a research collaboration to meet the significant and growing medical need in type 2...

STOCKHOLM, Sweden, July 7, 2004 (PRIMEZONE) -- Biovitrum AB, Stockholm and Artemis Pharmaceuticals GmbH, Cologne, have signed a Research Services Agreement concerning the generation of RNAi-modified...

STOCKHOLM, Sweden, June 11, 2004 (PRIMEZONE) -- Biovitrum has together with 12 of the most distinguished research groups in Europe, established a network of excellence, a research collaboration to...

STOCKHOLM, Sweden and REDWOOD CITY, Calif., June 08, 2004 (PRIMEZONE) -- Maxygen, Inc. (Nasdaq:MAXY) and Biovitrum AB today announced the signing of an agreement for the manufacture of Maxygen's...